AGUENNOUZ, M'hammed
 Distribuzione geografica
Continente #
EU - Europa 13.880
NA - Nord America 11.986
AS - Asia 6.989
SA - Sud America 2.536
Continente sconosciuto - Info sul continente non disponibili 488
AF - Africa 256
OC - Oceania 11
AN - Antartide 1
Totale 36.147
Nazione #
US - Stati Uniti d'America 11.716
RU - Federazione Russa 6.750
SG - Singapore 3.055
BR - Brasile 2.191
CN - Cina 2.002
IE - Irlanda 1.587
SE - Svezia 1.357
IT - Italia 1.252
DE - Germania 745
HK - Hong Kong 706
UA - Ucraina 512
FR - Francia 483
FI - Finlandia 416
VN - Vietnam 399
GB - Regno Unito 276
IN - India 184
PL - Polonia 173
AR - Argentina 118
CA - Canada 118
BD - Bangladesh 103
BE - Belgio 76
IQ - Iraq 70
MX - Messico 68
TR - Turchia 68
ZA - Sudafrica 67
EC - Ecuador 66
AT - Austria 58
ID - Indonesia 53
CO - Colombia 48
PK - Pakistan 46
JP - Giappone 45
MA - Marocco 45
UZ - Uzbekistan 45
CI - Costa d'Avorio 42
NL - Olanda 41
VE - Venezuela 34
CZ - Repubblica Ceca 32
CL - Cile 30
ES - Italia 26
TN - Tunisia 23
KE - Kenya 22
AZ - Azerbaigian 21
PY - Paraguay 21
SA - Arabia Saudita 20
EG - Egitto 18
CR - Costa Rica 17
KZ - Kazakistan 17
MY - Malesia 17
NP - Nepal 17
DZ - Algeria 14
LT - Lituania 14
IR - Iran 13
PE - Perù 13
PH - Filippine 13
IL - Israele 12
LB - Libano 12
JM - Giamaica 11
AE - Emirati Arabi Uniti 10
AL - Albania 10
HN - Honduras 10
DO - Repubblica Dominicana 9
PT - Portogallo 9
UY - Uruguay 9
EU - Europa 8
NI - Nicaragua 8
AU - Australia 7
KG - Kirghizistan 7
OM - Oman 7
RO - Romania 7
TH - Thailandia 7
BG - Bulgaria 6
BO - Bolivia 6
GT - Guatemala 6
JO - Giordania 6
PS - Palestinian Territory 6
RS - Serbia 6
SN - Senegal 6
CH - Svizzera 5
GR - Grecia 5
PR - Porto Rico 5
SK - Slovacchia (Repubblica Slovacca) 5
TW - Taiwan 5
KH - Cambogia 4
NO - Norvegia 4
NZ - Nuova Zelanda 4
PA - Panama 4
BA - Bosnia-Erzegovina 3
BY - Bielorussia 3
EE - Estonia 3
GA - Gabon 3
HR - Croazia 3
KR - Corea 3
LV - Lettonia 3
NG - Nigeria 3
QA - Qatar 3
SV - El Salvador 3
TT - Trinidad e Tobago 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AM - Armenia 2
BB - Barbados 2
Totale 35.628
Città #
Moscow 2.072
Dublin 1.586
Ashburn 1.550
Singapore 1.525
Dallas 1.379
Chandler 1.092
Jacksonville 1.065
Nyköping 830
Beijing 721
Hong Kong 706
San Jose 628
Council Bluffs 423
The Dalles 382
Messina 360
Princeton 296
Los Angeles 288
Medford 273
Munich 251
Lauterbourg 246
Cambridge 244
Ann Arbor 241
Des Moines 213
Dearborn 172
São Paulo 164
Warsaw 157
New York 137
Buffalo 132
Ho Chi Minh City 130
Boardman 127
Helsinki 91
Tianjin 89
Jinan 82
Wilmington 80
Shenyang 75
Hanoi 72
Santa Clara 72
Rio de Janeiro 70
Rome 69
Brussels 67
San Mateo 66
Turku 66
Woodbridge 63
Frankfurt am Main 61
Redondo Beach 61
Guangzhou 60
Lancaster 60
Belo Horizonte 59
Orem 59
Brooklyn 54
Hyderabad 49
Nanjing 49
Bremen 44
Houston 43
Abidjan 41
Curitiba 40
Tashkent 40
Tokyo 40
Vienna 40
Shanghai 39
Pune 38
Seattle 37
Hebei 36
Nuremberg 35
Atlanta 33
London 32
Montreal 32
Phoenix 32
Porto Alegre 32
Brasília 31
Columbus 30
Milan 30
Ningbo 30
Johannesburg 29
Catania 28
Chennai 28
Salvador 28
Zhengzhou 28
Hangzhou 27
Taizhou 27
Caltagirone 26
Haikou 26
Toronto 26
Campinas 24
Dong Ket 24
Guarulhos 24
Guayaquil 24
Norwalk 24
Quito 24
Baghdad 22
Denver 22
San Francisco 22
Baku 21
Falls Church 21
Mumbai 21
Nairobi 21
Amsterdam 20
Brno 20
Düsseldorf 20
Ottawa 20
Changsha 19
Totale 20.285
Nome #
Idrocefalo normoteso idiopatico (iNPH): nostra esperienza preliminare. 465
A NOVEL SERUM MICRORNA SIGNATURE TO SCREEN TRANSTHYRETIN-RELATED FAMILIAL AMYLOID POLYNEUROPATHY 369
A multicenter, randomized, double-blind, placebo-controlled trial of long-term ascorbic acid treatment in Charcot-Marie-Tooth disease type 1A (CMT-TRIAAL): the study protocol 332
A Phase 1/2 Study of Flavocoxid, an Oral NF-κB Inhibitor, in Duchenne Muscular Dystrophy 256
Clinical and pathological features of focal myositis 251
4-Methyl umbelliferone effects on cell proliferation in human glioma cells. 247
SIRT1 and SIRT2 Expression correlates with advanced disease and bone lesions in Multiple Myeloma 244
PDXK mutations cause polyneuropathy responsive to pyridoxal 5'-phosphate supplementation. 242
MiRNA expression profiling regulates necroptotic cell death in hepatocellular carcinoma 241
Mutations in the Neuronal Vesicular SNARE VAMP2 Affect Synaptic Membrane Fusion and Impair Human Neurodevelopment 235
A Nouvel serum MicroRNA signature to screen ATTR 233
Circulating miRNAs expression as potential biomarkers of mild traumatic brain injury 221
Analisi dello stato di metilazione del promoter di O6-methylguanine DNA methyltransferase (MGMT) e TMS1/ASC nei gliomi cerebrali diffusi di basso grado: possibili implicazioni cliniche e prognostiche. 220
Circulating microRNAs Profile in Patients With Transthyretin Variant Amyloidosis 218
A cytochemical study of apoptosis in metabolic myopathies 214
A life threatening case of β-enolase deficiency 205
MDR-1 gene polymorphisms G2677T and C3435T in a case of Hodgkin's variant of Richter's syndrome 202
Advances in Treatment of ATTRv Amyloidosis: State of the Art and Future Prospects 200
microRNA-10 and -221 modulate differential expression of Hippo signaling pathway in human astroglial tumors 200
Modulation of neuronal nitric oxide synthase and apoptosis by the isoflavone genistein in Mdx mice 197
miRNA regulation of Sirtuin-1 expression in human astrocytoma 197
A homozygous MED11 C-terminal variant causes a lethal neurodegenerative disease 196
Hippo signaling pathway is altered in Duchenne muscular dystrophy 192
Effect of exercise on telomere length and telomere proteins expression in mdx mice 192
NLRP3 inflammasome CSF expression and neuropsychological changes in idiopathic normal pressure hydrocephalus 189
Autoimmunity to heterogeneous nuclear ribonucleoprotein A1 in psoriatic patients and correlation with disease severity 187
Characterization and functional analysis of the human microRNA 363 in glioblastoma transfected cell lines 186
Prognostic value of HMGB1 and oxidative stress markers in multiple trauma patients: A single-centre prospective study 186
Analisi dello stato di metilazione del promoter di O6-methylguanine DNA methyltransferase (MGMT) e TMS1/ASC: possibili implicazioni cliniche e prognostiche nei gliomi cerebrali diffusi di basso grado 185
(+)-Lipoic Acid Reduces Lipotoxicity and Regulates Mitochondrial Homeostasis and Energy Balance in an In Vitro Model of Liver Steatosis 183
A case of vacuolar myopathy during the course of chronic hepatitis C. 182
Expression of the tumor necrosis factor receptor-associated factors I and 2 and regulation of the nuclear factor-kappa B antiapoptotic activity in human gliomas 181
Analysis of HBV integration in mitochondrial DNA of HepAD38 cells by the high-throughput HBV integration sequencing and RNASeq approaches 180
ANT1 is reduced in sporadic inclusion body myositis. 179
NfL as a biomarker in ATTRv amyloidosis: potential and limitations 178
A novel variant of GALC in a familial case of Krabbe disease: Insights from structural bioinformatics and molecular dynamics simulation 178
Role of inflammation and oxidative stress mediators in gliomas. 178
MiRNA expression profiling in human gliomas: upregulated miR-363 increases cell survival and proliferation 178
ANT1 expression and RAGE-NF-kB pathway activation in sporadic inclusion-body myositis 177
Analysis of lipid profile in lipid storage myopathy 177
Pilot study of flavocoxid in ambulant DMD patients. 174
Type I Hyperprolinemia Associated with Epilepsy and Mental Retardation Results from PRODH Gene Mutations in Three Sicilian Children. 170
ANT1 expression and RAGE-NF-kB pathway in sporadic inclusion body myositis. 170
Espressione differenziale di un panel di miRNA in tumori cerebrali astrogliali con diverso grado di malignità. 169
Asymptomatic hyperCKemia in a case of Danon disease due to a missense mutation in Lamp-2 gene 168
Activation of nuclear factor-kappa B in inflammatory myopathies and Duchenne muscular dystrophy 168
Methylome Analysis in Nonfunctioning and GH-Secreting Pituitary Adenomas 167
Type I hyperprolinemia and proline dehydrogenase (PRODH) mutations in four Italian children with epilepsy and mental retardation. 167
MicroRNA signatures predict dysregulated Vitamin D receptor and calcium pathways status in Limb Girdle muscle dystrophies (LGMD) 2A/2B. 167
Modulation of neural nitric oxide synthase by the isoflavone genistein promotes muscle regeneration in mdx mice 167
Activation of nuclear factor-κB in inflammatory myopathies and Duchenne muscular dystrophy 162
Ant1 expression and RAGE-NF-kB pathway activation in sporadic inclusion body myositis 162
Recurrent rhabdomyolysis due to muscle β-enolase deficiency: very rare or underestimated? 161
Clinical and genetic characterization in two families with muscle phosphofructokinase deficiency 156
Meccanismi anti-apoptotici nei gliomi. Ruolo dell'attività nucleare del nuclear factor-kb e dei suoi fattori di controllo. 154
MDR-1 polymorphisms (G2677T and C3435T) in B-chronic lymphocytic leukemia: an impact on susceptibility and prognosis. 153
A rare PANK2 deletion in the first north African patient affected with pantothenate kinase associated neurodegeneration 153
Activation of NF-kappaB pathway in Duchenne muscular dystrophy: relation to age 153
Expression of telomeric repeat binding factor-1 in astroglial bran tumors 152
Fatal R631C mutation is also present in the adult form of CPTII deficiency 152
Pilot study of flavocoxid in ambulant DMD patients. 152
Severe rhabdomyolysis in a patient with “Heat Stroke” 152
MicroRNAs expression in pituitary tumors: differences related to functional status, pathological features, and clinical behavior 152
Pilot study of flavocoxid in ambulant DMD patients. 152
Charcot-Marie-Tooth disease: experience from a large Italian tertiary neuromuscular center 151
Clinical, biochemical and genetic features in muscle phosphofructokinase deficiency 150
Clinical and genetic charactherization in two families with muscle phosphofructokinase deficiency 150
Miopatie metaboliche 150
Expression of transglutaminase 2 does not differentiate focal myositis from generalized inflammatory myopathies 150
Meccanismi antiapoptotici nf-kb-mediati in gliomi umani in vivo. 150
Telomere shortening is associated to TRF1 and PARP1 overexpression in Duchenne muscular dystrophy 150
AMPA receptor GluA2 subunit defects are a cause of neurodevelopmental disorders 150
Ascorbic acid in Charcot-Marie-Tooth disease type 1A (CMT-TRIAAL and CMT-TRAUK): a double-blind randomised trial 149
Mutations in NKX6-2 Cause Progressive Spastic Ataxia and Hypomyelination 149
ANT1 expression and RAGE-NF-kB pathway in sporadic inclusion body myositis 148
Sarcoglycans in cerebral cortex of the rat: an immunohistochemical and molecular study. 146
Activation and localization of transcription factor NF-KB in peripheral neuropathies of different origin. 145
Matrix Metalloproteinase 9 and Transglutaminase 2 Expression at the Ocular Surface in Patients with Different Forms of Dry Eye Disease 145
Biallelic mutations in neurofascin cause neurodevelopmental impairment and peripheral demyelination 145
Telomere shortening and telomere-associated proteins in Duchenne muscular dystrophy. 143
Clinical features and new molecular findings in muscle phosphofructokinase deficiency (GSD type VII). 143
miR-21 and 221 upregulation and miR-181b downregulation in human grade II-IV astrocytic tumors 143
Calpain 3 deficiency in Quail Eater's disease 142
Bi-allelic genetic variants in the translational GTPases GTPBP1 and GTPBP2 cause a distinct identical neurodevelopmental syndrome 141
Evidence of calpain and caspase-3-like activation in CSF of severe human traumatic brain injury 140
Inverse correlation between TRF-1 (telomeric-repeat binding factor 1) and histological grade of malignant brain tumors 139
Clinical heterogeneity and molecular basis of myoadenilate deaminase deficiency 137
Meccanismi antiapoptotici NF-kB-mediati in gliomi umani in vivo. 137
CXCL12/CXCR4 axis supports mitochondrial trafficking in tumor myeloma microenvironment 137
Espressione di ANT1 e attivazione della via RAGE-NF-kB nella miosite a corpi inclusi. 136
Expression of the trascription factor NFkB in different muscular dystrophies 135
Espressione del telomeric Repeat Binding Factor-1 (TRF-1) nei tumori cerebrali della serie astrogliale: possibili implicazioni clinico-terapeutiche. 135
Differential expression of Hippo signaling pathway in human astroglial tumors 132
Implication of SIRT1 and its downstream pathways in dystrophic process. 132
Meningiomas and proteomics: Focus on new potential biomarkers and molecular pathways 132
study of flavocoxid in ambulant DMD patients. 131
Dyscondrosteosis in a child with Becker muscular dystrophy: an unreported association between Xp21 gene (DMD/BMD) deletion and a novel homozygous SHOX gene mutation 130
Novel SHOX Gene Mutation in a Short Boy with Becker Muscular Dystrophy: Double Trouble in Two Adjacent Genes. 127
Studio dell'espressione genica della metalloproteinasi 3 e degli inibitori TIMP-1 e TIMP-2 nei meningiomi cerebrali 127
Late-onset mitochondrial neuromyopathy: an age-related phenomenon ? 127
Totale 17.600
Categoria #
all - tutte 121.810
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 121.810


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.833 0 232 31 72 96 27 138 83 35 234 238 647
2022/20234.491 372 381 232 322 348 423 72 258 1.907 17 107 52
2023/20241.197 90 186 77 92 119 220 37 79 12 92 27 166
2024/20255.938 108 61 114 333 283 184 148 1.318 1.406 354 607 1.022
2025/202616.552 872 1.236 1.423 1.165 1.199 3.545 2.090 1.870 1.965 667 293 227
2026/2027811 257 554 0 0 0 0 0 0 0 0 0 0
Totale 36.147